TNF-α信号干预微泡miRNA装配调控肿瘤细胞传染性

批准号:
81500136
项目类别:
青年科学基金项目
资助金额:
18.0 万元
负责人:
朱晓健
依托单位:
学科分类:
H0809.白血病
结题年份:
2018
批准年份:
2015
项目状态:
已结题
项目参与者:
周晓曦、王珏、王迪、李青、高丽丽、曾辰、唐颖、周盼
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
微信扫码咨询
中文摘要
申请人前期工作及近期文献均证明,部分肿瘤细胞分泌的微泡(MV)能够将健康同源细胞驯化成肿瘤,被称为癌症细胞的“传染性”。截至目前,细胞外信号如何影响MV致瘤能力尚未可知,无法提供便捷、高效的调控手段。我们发现TNF-α信号极有可能串联MV的释放及其内容物组装;因此本课题拟探讨TNF-α信号对MV致瘤能力的影响及其分子机制。我们拟首先研究TNF-α信号对白血病MV miRNA表达谱等生物学特性的影响;同时证明TNF-α通过诱导MV中miRNA表达谱改变影响其致瘤能力,在此基础上,初步探讨TNF-α信号影响MV中miRNA分子组装的机制。本课题的完成,有望首次提出TNF-α等细胞外信号通路对MV致瘤能力的影响及机制,TNF-α有望成为干预MV致瘤性的重要调控靶点;同时,初步阐明了MV内容物组装的分子机制及其干预途径,为后期调控MV内容物的研究提供了重要的方法学选择和关键的研究切入点。
英文摘要
Microvesicles (MV), also termed as microparticles, have been described as a novel and important mechanism of intercellular signal communication via fusing with the plasma membrane of the target cell and discharging their cargo into the cytosol. By facilitating the horizontal transfer of bioactive molecules such as proteins, RNAs and microRNAs, MVs are now thought to have vital roles in tumor invasion and metastases, inflammation, coagulation and stem-cell renewal. We have demonstrated that BCR-ABL1–positive MVs could initiate malignant transformation of normal cells (Leukemia, 2014, 28(8):1666-75). Similar work with breast cancer derived MVs, was performed by Melo et al (Cancer Cell, 2014 Nov 10;26(5):707-21) eight months later. Both our papers demonstrated that miRNAs were key key regulatory molecules of tumorigenesis induced by MV. No definite conclusion has been given yet on the tumorigenesis induced by MV about extracellular signals. A few papers have showed that TNF-alpha(α) could alter miRNA-mediated communication by endothelial MVs. Besides, our previous bioinformatics have confirmed that TNF-α might also have an impact on the release of MVs. The aim of this subject is to investigate whether TNF-α could influence the transformation ablility of MVs via altering the miRNA profiles in MV..In this subject, we will figure out the effects of TNF-α signal on MV releasing from leukemia cells. More importantly, we will prove that the transformation ability of MV could be altered via altering the miRNA profiles in MV when TNF-α pathway was blocked or enchanced. Besides, this subject would explore the molecular mechanisms for loading miRNA into MVs. Findings of this subject will sheed much-needed light on the effect of extracellular signal (such as TNF-α) driving malignant reprogramming induced by MV. Furthermore, TNF-α itself could act as an warning indicator and a novel target to regulate the transformation ability of MVs. It also presented a unique opportunity to prospectively study the mechanisms undergone by TNF-α, loading their miRNAs into MV, serving as a convenient and operable model for investigating MVs.
恶性肿瘤细胞分泌囊泡(MV)的生物学功能是目前该领域研究的焦点所在,MV通过传递其内容物发挥生物学功能。本项目在前期工作的基础上,探讨肿瘤坏死因子α(TNF-α)信号对肿瘤细胞MV分泌及其内容物的影响与机制。我们首先应用CRISPR/Cas9基因编辑技术构建了TNF-α敲除的K562细胞系;继而通过菌落形成细胞分析、皮下肿瘤模型、RT-qPCR、miRNA-seq、TargetScan数据库、生物信息学和液相色谱-质谱(LC-MS)等方法,对比发现K562 TNFα-/-相比于野生型的K562细胞,其增殖、长期克隆形成、裸鼠体内成瘤能力均显著降低,K562 TNFα-/-与伊马替尼共培养时凋亡率显著增加,提示对药物更加敏感。代谢组学检测发现K562 TNFα-/-抑制柠檬酸循环,增加淀粉、蔗糖、氨基糖和核苷酸糖代谢。miRNA表达谱分析发现K562 TNFα-/-与K562之间显著差异表达的miRNA导致细胞周期,P13K-AkT等癌症相关通路低表达。在此基础上,对不同K562细胞分泌的MV进行了进一步分析,首先发现K562TNFα-/- -MV相比 K562-MV及空载体组来源MV,其诱导造血干祖细胞恶性转化的效率显著降低,诱导时间延长。实时定量PCR 检测提示各组MV中BCR-ABL1 mRNA 表达水平并无明显差异。小RNA测序显示 K562TNFα-/--MV 中 miR-28-3p,miR-150-5p,miR-451a,miR-1468-5p,let-7c-5p,miR-7641,miR-125b-5p,miR-10b-5p等表达显著上调。进一步的生物信息学分析表明差异表达的 miRNA 与转录因子构成一个复杂调控网络,其功能是抑制肿瘤发生过程中所必需的基因组不稳定性,进而抑制MV诱导的恶性转化。上述工作已投稿于OncoTargets and Therapy,小修中。本课题的完成,首次提出以 TNF-α为代表的细胞外信号通路对MV内容物组装的具有重要影响,丰富和完善了MV及肿瘤细胞内相关miRNA 的功能学研究,同时也加深了对 TNF-α作用的认识,其有望成为干预MV致瘤性及治疗CML的重要信号选择。本课题共标注发表SCI论文5篇,中文核心2篇,其中4篇SCI论文,2篇中文期刊申请人均为第一/通讯作者(含共同),形成硕士论文一篇。
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
DOI:10.1080/10428194.2017.1421755
发表时间:2018
期刊:Leuk Lymphoma
影响因子:--
作者:Cui Jieke;Zhu Zunmin;Liu Songya;Li Qing;Meng Li;Cheng Hui;Zhong Zhaodong;Li Weiming;You Yong;Zhu Xiaojian;Zou Ping
通讯作者:Zou Ping
DOI:10.3760/cma.j.issn.0253-2727.2018.12.005
发表时间:2018
期刊:中华血液学杂志
影响因子:--
作者:朱晓健;游泳;段明辉;朱雨;刘兵城;陈苏宁;杜新
通讯作者:杜新
The epigenetic effect of microRNA in BCR-ABL1‑positive microvesicles during the transformation of normal hematopoietic transplants
BCR-ABL1-阳性微泡中microRNA在正常造血移植转化过程中的表观遗传效应
DOI:10.3892/or.2017.5966
发表时间:2017
期刊:ONCOLOGY REPORTS
影响因子:4.2
作者:Na Shen;Lin Jiang;Qing Li;Jieke Cui;Shu Zhou;Fanjun Cheng;Zhaodong Zhong;Li Meng;Yong You;Xiaojian Zhu;Ping Zou
通讯作者:Ping Zou
DOI:10.3760/cma.j.issn.1009-9921.2017.10.007
发表时间:2017
期刊:白血病·淋巴瘤
影响因子:--
作者:李青;程辉;游泳;仲照东;黎纬明;孟力;朱晓健;邹萍
通讯作者:邹萍
A clinical observation of Chinese chronic myelogenous leukemia patients after discontinuation of tyrosine kinase inhibitors.
中国慢性粒细胞白血病患者停用酪氨酸激酶抑制剂后的临床观察
DOI:10.18632/oncotarget.11281
发表时间:2016-09-06
期刊:Oncotarget
影响因子:--
作者:Li Q;Zhong Z;Zeng C;Meng L;Li C;Luo Y;Wang H;Li W;Wang J;Cheng F;Guo A;Liu S;Jin C;Zhu X;You Y;Zou P
通讯作者:Zou P
靶向BCR-ABL1融合基因的TCR-like CAR-T在Ph阳性白血病中的作用及机制探索
- 批准号:--
- 项目类别:面上项目
- 资助金额:52万元
- 批准年份:2022
- 负责人:朱晓健
- 依托单位:
国内基金
海外基金
